Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Current Medical Research and Opinion|December 21, 2019
Healthcare resource utilization and costs among nonvalvular atrial fibrillation patients initiating rivaroxaban or warfarin in skilled nursing facilities: a retrospective cohort studyV Simon Mittal, Bingcao Wu, Ji Song, et al.Stroke|January 1, 2020
Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and WarfarinMark Alberts, Yen-Wen Chen, Jennifer H Lin, et al.Journal of Orthopaedic Trauma|August 2, 2005
An in vivo rabbit model for cartilage trauma: a preliminary study of the influence of impact stress magnitude on chondrocyte death and matrix damageDejan Milentijevic, Iván F Rubel, Allan S L Liew, et al.Journal of Medical Economics|January 27, 2021
Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarinDejan Milentijevic, Jennifer H Lin, Yen-Wen Chen, et al.Journal of Medical Economics|September 8, 2020
Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the USDejan Milentijevic, Guillaume Germain, François Laliberté, et al.Journal of Medical Economics|December 11, 2019
Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancerAlok A Khorana, Keith R McCrae, Dejan Milentijevic, et al.Ophthalmic Genetics|November 10, 2025
Social media-derived patient perspectives on the burden of inherited retinal diseases, including retinitis pigmentosaCho-Han Lee, Rebecca Crawford, Sheila Hickson-Curran, et al.Journal of Medical Economics|October 27, 2016
Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolismCraig I Coleman, Christopher Baugh, Concetta Crivera, et al.The American Journal of Sports Medicine|May 19, 2009
Chondrocyte death and cartilage degradation after autologous osteochondral transplantation surgery in a rabbit modelLawrence V Gulotta, Jonas R Rudzki, David Kovacevic, et al.Journal of Medical Economics|May 21, 2019
Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulantsMichael Streiff, Dejan Milentijevic, Keith R McCrae, et al.Pageof 4